Angiogenic, antiangiogenic factors linked to preeclampsia risk in diabetes

08/18/2013 | Medscape (free registration)

Increased levels of antiangiogenic factors, including soluble fms-like tyrosine kinase-1 and soluble endoglin, and lower levels of placental growth factor, an angiogenic factor, during the second trimester of pregnancy were associated with a higher preeclampsia risk in women with type 1 diabetes, a study found. Researchers reported in the journal Diabetes Care that while established clinical risk factors for preeclampsia are reliable, the study results "also suggest that angiogenic factors provide added clinical value when predicting risk."

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX